Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guy Nohra Insider Profile
4 Followers
Guy Nohra, Director at ZS Pharma, holds 69.72K shares in Bioventus (Ticker: BVS), holds 6.45M shares in Allakos (Ticker: ALLK), holds 0.00 shares in ZS Pharma (Ticker: ZSPH).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+19.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Guy Nohra holds in companies
Most Profitable Insider Trade
The most profitable trade made by Guy Nohra
Guy Nohra's Trading History
ZS Pharma
Dec 21, 2015
―
Uninformative Sell
90.00K
$0.00
Allakos
Mar 08, 2021
Ten Percent Owner
Informative Sell
2.88M
$7.90M
Bioventus
Aug 18, 2023
Director
Uninformative Buy
―
$356.95K
KalVista Pharmaceuticals
Apr 14, 2015
Director
Uninformative Buy
―
$52.95M
Talphera
Sep 23, 2013
Director
Uninformative Sell
1.67M
$2.49M
Avadel Pharmaceuticals
―
See Footnotes
―
$117.13K
Cutera
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Guy Nohra's performance on stock
You May Also Like
Guy Nohra insider profile FAQ
What is the percentage of profitable transactions made by Guy Nohra?
The percentage of profitable transactions made by Guy Nohra is 50%.
What is the average return per transaction made by Guy Nohra?
The average return per transaction made by Guy Nohra is 19.30%.
What stocks does Guy Nohra hold?
Guy Nohra holds: ZSPH, ALLK, BVS, KALV, TLPH, AVDL, CUTR stocks.
What was Guy Nohra’s latest transaction?
Guy Nohra latest transaction was an Uninformative Buy of ―.
What was Guy Nohra's most profitable transaction?
Guy Nohra’s most profitable transaction was an Informative Sell of ALLK stock on March 8, 2021. The return on the trade was 95.70%.
What is Guy Nohra's role in ZS Pharma?
Guy Nohra's role in ZS Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.